Publicaciones en las que colabora con MARÍA DEL CAMINO GUTIÉRREZ CORBO (11)

2022

  1. Axenic interspecies and intraclonal hybrid formation in Leishmania: Successful crossings between visceral and cutaneous strains

    PLoS neglected tropical diseases, Vol. 16, Núm. 2, pp. e0010170

2021

  1. Bioluminescent Imaging Identifies Thymus, As Overlooked Colonized Organ, in a Chronic Model of Leishmania donovani Mouse Visceral Leishmaniasis

    ACS Infectious Diseases, Vol. 7, Núm. 4, pp. 871-883

  2. Ex Vivo Phenotypic Screening of Two Small Repurposing Drug Collections Identifies Nifuratel as a Potential New Treatment against Visceral and Cutaneous Leishmaniasis

    ACS Infectious Diseases, Vol. 7, Núm. 8, pp. 2390-2401

  3. Reproduction in trypanosomatids: Past and present

    Biology, Vol. 10, Núm. 6

2020

  1. Mannose-decorated dendritic polyglycerol nanocarriers drive antiparasitic drugs to leishmania infantum-infected macrophages

    Pharmaceutics, Vol. 12, Núm. 10, pp. 1-21

2019

  1. A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery

    PLoS Neglected Tropical Diseases, Vol. 13, Núm. 2

  2. Antiparasitic effect of synthetic aromathecins on Leishmania infantum

    BMC Veterinary Research, Vol. 15, Núm. 1

  3. Current and promising novel drug candidates against visceral leishmaniasis

    Pure and Applied Chemistry

  4. Topoisomerase IB poisons induce histone H2A phosphorylation as a response to DNA damage in Leishmania infantum

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 11, pp. 39-48

  5. Walking a tightrope: drug discovery in visceral leishmaniasis

    Drug Discovery Today, Vol. 24, Núm. 5, pp. 1209-1216

2017

  1. PEGylated Dendritic Polyglycerol Conjugate Delivers Doxorubicin to the Parasitophorous Vacuole in Leishmania infantum Infections

    Macromolecular Bioscience, Vol. 17, Núm. 10